Abiopharma

📋 MANUELA VALENTE (Officer) plans to sell 3K shares of SOPHIA GENETICS SA (at $4.67 each, total $13K) Filed: Jan 05, 2026 | ID: 000132

📋 Michael Benkowitz (Officer) plans to sell 90K shares of United Therapeutics Corporation (at $496.72 each, total $44.7M) Filed: Jan 05, 2026 | ID: 000130

📋 BERNADETTE CONNAUGHTON (Director) plans to sell 2K shares of HALOZYME THERAPEUTICS, INC. (at $70.31 each, total $141K) Filed: Jan 05, 2026 | ID: 000129

Smith Robert Paul JR 🟢 acquired 656.2K shares (1 derivative) of Gossamer Bio, Inc. (GOSS) at $2.88 ($1.6M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

Director Chan Gerald 🟢 acquired 22.6K shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $25.12 Transaction Date: Jan 01, 2026 | Filing ID: 000012

Director BOURLA ALBERT 🟢 acquired 24 shares (1 derivative) of PFIZER INC (PFE) Transaction Date: Dec 31, 2025 | Filing ID: 000163

Director Rosa David A 🟢 acquired 2.5K shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) at $0.76 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Aranda Richard 🟢 acquired 656.2K shares (1 derivative) of Gossamer Bio, Inc. (GOSS) at $2.88 ($1.6M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Doukeris Michel D 🟢 acquired 128 shares of ECOLAB INC. (ECL) Transaction Date: Dec 31, 2025 | Filing ID: 000002

Woods-Keisling Sharon 🟢 acquired 26.3K shares (2 derivative) of Spok Holdings, Inc (SPOK) Transaction Date: Jan 02, 2026 | Filing ID: 002564

Peterson Caryn 🟢 acquired 590.8K shares (1 derivative) of Gossamer Bio, Inc. (GOSS) at $2.88 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director O'Brien Stephanie Monaghan 🟢 acquired 22.6K shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $25.12 Transaction Date: Jan 01, 2026 | Filing ID: 000011

Director FONTEYNE PAUL R. 🟢 acquired 22.6K shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $25.12 Transaction Date: Jan 01, 2026 | Filing ID: 000010

WALLACE MICHAEL W 🟢 acquired 68.2K shares (2 derivative) of Spok Holdings, Inc (SPOK) Transaction Date: Jan 02, 2026 | Filing ID: 002553

Director Walbert Keli 🟢 acquired 22.6K shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $25.12 Transaction Date: Jan 01, 2026 | Filing ID: 000009